Amneal Pharmaceutical is now shipping Bexarotene Gel, 1%, an AB-rated generic equivalent to Targretin®. The Amneal product is sold in a carton containing one 60 gram aluminum tube. The gel is a clear, colorless gelled solution with a homogenous consistency.
Approved on April 27 of this year as an Abbreviated New Drug Application (ANDA) with CGT exclusivity by the US FDA, the Ameal product is the first true generic equivalent for Targretin® currently on the market.
According to IQVIA®, U.S. annual sales for Bexarotene Gel, 1%, for the 12 months ended April 2022 were $21,804,343.
Amneal Bexarotene Gel, 1% is available through wholesalers and distributors as well as directly to the trade.
Click here for full prescribing information.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully integrated pharmaceutical company focused on the
development, manufacturing, and distribution of generic and specialty drug
products. The Company has operations in North America, Asia, and Europe,
working together to bring high-quality medicines to patients primarily within
the United States.
Amneal has an extensive portfolio of approximately 250
product families and is expanding its portfolio to include complex dosage forms,
including biosimilars, in a broad range of therapeutic areas. The Company also
markets a portfolio of branded pharmaceutical products through its Specialty
segment focused principally on central nervous system and endocrine disorders.
The Company also owns 65% of AvKARE. AvKARE provides
pharmaceuticals, medical and surgical products and services primarily to
governmental agencies, primarily focused on serving the Department of Defense
and the Department of Veterans Affairs. AvKARE is also a packager and wholesale
distributor of pharmaceuticals and vitamins to its retail and institutional
customers who are located throughout the United States focused primarily on
offering 340b-qualified entities products to provide consistency in care and
pricing. For more information, visit www.amneal.com.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.
